Factors impacting vaccine hesitancy toward Coronavirus disease-19 (COVID-19) vaccination in Brooklyn, New York. Issue 11 (2nd November 2021)

• Record Type: Journal Article
• Authors: Smith-Norowitz, Tamar A.; Silverberg, Jonathan I.; Norowitz, Esther M.; Kohlhoff, Stephan; Hammerschlag, Margaret R
• Is Part Of: Human vaccines & immunotherapeutics. Volume 17:Issue 11(2021)
• Page Start: 4013
• Page End: 4014
• Publication Date: 2021-11-02
• Subjects: COVID-19 -- COVID-19 vaccine -- seasonal influenza vaccine -- vaccine hesitancy -- New York; Vaccines -- Periodicals; 615.372
• DOI: 10.1080/21645515.2021.1948786
• Languages: English
• ISSNs: 2164-5515

Abstract

Abstract: The Coronavirus disease-2019 (COVID-19) pandemic led to the development of several candidate vaccines. However, current research suggests that the potential of successful vaccines is tempered by vaccine skepticism or hesitancy. If vaccine efficacy is 80%, then the herd immunity required from vaccination is about 75-90%. The aim of the current study was to study factors impacting COVID-19 vaccine hesitancy in a representative sample of adults (age≥18 years) in a COVID-19 hotspot Abbreviations: COVID-19: coronavirus disease-19